Percutaneous coronary intervention for unprotected left main coronary artery stenosis
Seung-Jung Park1, Young-Hak Kim
1Seung-Jung Park, Young-Hak Kim, Cardiac Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
Insights
Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) offers acceptable outcomes for unprotected left main coronary artery stenosis (LMCA). Further studies are needed to compare PCI with DES against coronary artery bypass graft (CABG) surgery.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Hemodynamically significant left main coronary artery stenosis (LMCA) affects approximately 4% of diagnostic coronary angiograms.
- Unprotected LMCA stenosis occurs when there are no patent grafts to the left coronary artery or left circumflex artery.
- Historically, coronary artery bypass graft (CABG) surgery has shown reduced mortality compared to medical treatment for LMCA stenosis.
Purpose of the Study:
- To evaluate the long-term outcomes of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) for unprotected LMCA stenosis.
- To inform clinical decision-making for patients unsuitable for or refusing CABG surgery.
- To highlight the need for future randomized trials comparing PCI with DES versus CABG for unprotected LMCA stenosis.
Main Methods:
- Review of previous randomized studies on revascularization for LMCA stenosis.
- Analysis of outcomes associated with PCI using DES in unprotected LMCA stenosis.
- Consideration of patient risk factors and treatment preferences.
Main Results:
- Current guidelines recommend CABG over PCI for unprotected LMCA stenosis due to proven surgical benefits and historical high restenosis rates with bare metal stents.
- The advent of DES has led to acceptable long-term outcomes for PCI in treating unprotected LMCA stenosis.
- PCI with DES is increasingly utilized for high-risk patients or those who refuse CABG.
Conclusions:
- PCI with DES presents a viable alternative for unprotected LMCA stenosis, particularly in specific patient populations.
- Further randomized controlled trials are essential to directly compare the efficacy of PCI with DES versus CABG for unprotected LMCA stenosis.
- Such studies will advance clinical knowledge and guide the optimal treatment strategy for this critical condition.
Abstract:
Hemodynamically significant left main coronary artery stenosis (LMCA) is found in around 4% of diagnostic coronary angiograms and is known as unprotected LMCA stenosis if the left coronary artery and left circumflex artery has no previous patent grafts. Previous randomized studies have demonstrated a significant reduction in mortality when revascularization by coronary artery bypass graft (CABG) surgery was undertaken compared with medical treatment. Therefore, current practice guidelines do not recommend percutaneous coronary intervention (PCI) for such a lesion because of the proven benefit of surgery and high rates of restenosis with the use of bare metal stents. However, with the advent of drug-eluting stents (DES), the long term outcomes of PCI with DES to treat unprotected LMCA stenoses have been acceptable. Therefore, apart from the current guidelines, PCI for treatment of unprotected LMCA stenosis is often undertaken in individuals who are at a very high risk of CABG or refuse to undergo a sternotomy. Future randomized studies comparing CABG vs PCI using DES for treatment of unprotected LMCA stenosis would be a great advance in clinical knowledge for the adoption of appropriate treatment.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome I: Introduction
Mitral Stenosis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care

